Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis.

Federico SalomoneWalter CurrentiGiovanni MagrìIvo BoškoskiShira Zelber-SagiFabio Galvano

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

Obese patients with advanced liver fibrosis, treated with 6-month IGB, can achieve regression of fibrosis as assessed by reduction of liver stiffness and FIB-4. Randomized controlled trials are needed to confirm these findings.

Keyphrases

liver fibrosis
randomized controlled trial
adipose tissue
metabolic syndrome
type diabetes
weight loss
obese patients
clinical trial
newly diagnosed
meta analyses